instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Intravenous lidocaine infusion in a case of severe COVID-19 infection.
A subset of patients with COVID-19 develops a severe inflammatory response that may lead to respiratory and multiorgan failure. Effective treatment strategies to mitigate or interrupt this self-destructive inflammatory process are limited. The local... | HYDROXYCHLOROQUINE SULFATE | DrugsGivenReaction | CC BY-NC-SA | 34759566 | 20,879,994 | 2021 |
What is the weight of the patient? | Intravenous lidocaine infusion in a case of severe COVID-19 infection.
A subset of patients with COVID-19 develops a severe inflammatory response that may lead to respiratory and multiorgan failure. Effective treatment strategies to mitigate or interrupt this self-destructive inflammatory process are limited. The local... | 77 kg. | Weight | CC BY-NC-SA | 34759566 | 20,879,994 | 2021 |
What was the administration route of drug 'OXYGEN'? | Intravenous lidocaine infusion in a case of severe COVID-19 infection.
A subset of patients with COVID-19 develops a severe inflammatory response that may lead to respiratory and multiorgan failure. Effective treatment strategies to mitigate or interrupt this self-destructive inflammatory process are limited. The local... | Nasal | DrugAdministrationRoute | CC BY-NC-SA | 34759566 | 20,903,349 | 2021 |
What was the outcome of reaction 'Electrocardiogram QT prolonged'? | Intravenous lidocaine infusion in a case of severe COVID-19 infection.
A subset of patients with COVID-19 develops a severe inflammatory response that may lead to respiratory and multiorgan failure. Effective treatment strategies to mitigate or interrupt this self-destructive inflammatory process are limited. The local... | Recovered | ReactionOutcome | CC BY-NC-SA | 34759566 | 20,879,994 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Comparing adverse effects, short term outcomes, and cost implications of hyperthermic intravesical chemotherapy with Mitomycin-C and intravesical bacillus Calmette-Guerin instillation (Moscow-I strain) in the management of intermediate and high-risk nonmuscle invasive bladder cancer.
The recommended treatment for inter... | MITOMYCIN | DrugsGivenReaction | CC BY-NC-SA | 34759657 | 20,101,108 | 2021 |
What was the administration route of drug 'MITOMYCIN'? | Comparing adverse effects, short term outcomes, and cost implications of hyperthermic intravesical chemotherapy with Mitomycin-C and intravesical bacillus Calmette-Guerin instillation (Moscow-I strain) in the management of intermediate and high-risk nonmuscle invasive bladder cancer.
The recommended treatment for inter... | Intravesical | DrugAdministrationRoute | CC BY-NC-SA | 34759657 | 20,101,108 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.
OBJECTIVE
The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solu... | ACETAZOLAMIDE, INDOMETHACIN, INFLIXIMAB, KETOROLAC TROMETHAMINE, PREDNISOLONE ACETATE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-SA | 34759667 | 20,194,775 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.
OBJECTIVE
The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solu... | ACETAZOLAMIDE, INDOMETHACIN, INFLIXIMAB, KETOROLAC TROMETHAMINE, PREDNISOLONE ACETATE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-SA | 34759667 | 20,194,775 | 2021 |
What was the administration route of drug 'INDOMETHACIN'? | Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.
OBJECTIVE
The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solu... | Topical | DrugAdministrationRoute | CC BY-NC-SA | 34759667 | 20,194,775 | 2021 |
What was the administration route of drug 'INFLIXIMAB'? | Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.
OBJECTIVE
The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 34759667 | 20,194,775 | 2021 |
What was the administration route of drug 'KETOROLAC TROMETHAMINE'? | Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.
OBJECTIVE
The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solu... | Topical | DrugAdministrationRoute | CC BY-NC-SA | 34759667 | 20,194,775 | 2021 |
What was the administration route of drug 'PREDNISOLONE ACETATE'? | Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.
OBJECTIVE
The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solu... | Topical | DrugAdministrationRoute | CC BY-NC-SA | 34759667 | 20,194,775 | 2021 |
What was the dosage of drug 'KETOROLAC TROMETHAMINE'? | Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.
OBJECTIVE
The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solu... | UNK UNK, TID | DrugDosageText | CC BY-NC-SA | 34759667 | 20,194,775 | 2021 |
What was the dosage of drug 'PREDNISOLONE ACETATE'? | Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.
OBJECTIVE
The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solu... | UNK UNK, TID | DrugDosageText | CC BY-NC-SA | 34759667 | 20,194,775 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysphemia'. | Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering.
Childhood-Onset Fluency Disorder (Stuttering) is a neurodevelopmental disorder in which disturbances occur in the normal fluency and time patterning of speech. While the dopamine system has been well-described in its neurophysiology, there current... | ARIPIPRAZOLE, LURASIDONE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 34759847 | 20,490,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering.
Childhood-Onset Fluency Disorder (Stuttering) is a neurodevelopmental disorder in which disturbances occur in the normal fluency and time patterning of speech. While the dopamine system has been well-described in its neurophysiology, there current... | ARIPIPRAZOLE, LURASIDONE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 34759847 | 20,490,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering.
Childhood-Onset Fluency Disorder (Stuttering) is a neurodevelopmental disorder in which disturbances occur in the normal fluency and time patterning of speech. While the dopamine system has been well-described in its neurophysiology, there current... | ARIPIPRAZOLE, LURASIDONE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 34759847 | 20,490,333 | 2021 |
What was the outcome of reaction 'Dysphemia'? | Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering.
Childhood-Onset Fluency Disorder (Stuttering) is a neurodevelopmental disorder in which disturbances occur in the normal fluency and time patterning of speech. While the dopamine system has been well-described in its neurophysiology, there current... | Recovered | ReactionOutcome | CC BY | 34759847 | 20,490,333 | 2021 |
What was the outcome of reaction 'Off label use'? | Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering.
Childhood-Onset Fluency Disorder (Stuttering) is a neurodevelopmental disorder in which disturbances occur in the normal fluency and time patterning of speech. While the dopamine system has been well-described in its neurophysiology, there current... | Recovered | ReactionOutcome | CC BY | 34759847 | 20,490,333 | 2021 |
What was the outcome of reaction 'Therapy non-responder'? | Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering.
Childhood-Onset Fluency Disorder (Stuttering) is a neurodevelopmental disorder in which disturbances occur in the normal fluency and time patterning of speech. While the dopamine system has been well-described in its neurophysiology, there current... | Recovered | ReactionOutcome | CC BY | 34759847 | 20,490,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuroleptic malignant syndrome'. | Creutzfeldt-Jakob disease: A case report.
Creutzfeldt-Jakob disease (CJD) as a life-threatening neurodegenerative disorder is not usually diagnosed in early stages of the disease because of a variety in its clinical manifestations. This study aimed to present a middle-aged woman with psychiatric symptoms who ultimately... | DULOXETINE, FLUPHENAZINE, NANDROLONE DECANOATE, OLANZAPINE, TRIHEXYPHENIDYL, VALPROIC ACID, VENLAFAXINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34760082 | 20,543,727 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood glucose increased'. | Therapeutic challenge: Unusual coexistence of idiopathic central diabetes insipidus and diabetes mellitus in a male with vitiligo.
Idiopathic central diabetes insipidus (DI) is a rare endocrine disorder that results from total or partial deficiency of vasopressin secretion. It is idiopathic when the cause is unknown, b... | HYDROCHLOROTHIAZIDE | DrugsGivenReaction | CC BY | 34760083 | 20,137,637 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetes mellitus'. | Therapeutic challenge: Unusual coexistence of idiopathic central diabetes insipidus and diabetes mellitus in a male with vitiligo.
Idiopathic central diabetes insipidus (DI) is a rare endocrine disorder that results from total or partial deficiency of vasopressin secretion. It is idiopathic when the cause is unknown, b... | CARBAMAZEPINE, CHLORPROPAMIDE, HYDROCHLOROTHIAZIDE | DrugsGivenReaction | CC BY | 34760083 | 20,385,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Therapeutic challenge: Unusual coexistence of idiopathic central diabetes insipidus and diabetes mellitus in a male with vitiligo.
Idiopathic central diabetes insipidus (DI) is a rare endocrine disorder that results from total or partial deficiency of vasopressin secretion. It is idiopathic when the cause is unknown, b... | CARBAMAZEPINE, CHLORPROPAMIDE, HYDROCHLOROTHIAZIDE | DrugsGivenReaction | CC BY | 34760083 | 20,372,357 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Therapeutic challenge: Unusual coexistence of idiopathic central diabetes insipidus and diabetes mellitus in a male with vitiligo.
Idiopathic central diabetes insipidus (DI) is a rare endocrine disorder that results from total or partial deficiency of vasopressin secretion. It is idiopathic when the cause is unknown, b... | HYDROCHLOROTHIAZIDE | DrugsGivenReaction | CC BY | 34760083 | 20,137,637 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Therapeutic challenge: Unusual coexistence of idiopathic central diabetes insipidus and diabetes mellitus in a male with vitiligo.
Idiopathic central diabetes insipidus (DI) is a rare endocrine disorder that results from total or partial deficiency of vasopressin secretion. It is idiopathic when the cause is unknown, b... | HYDROCHLOROTHIAZIDE | DrugsGivenReaction | CC BY | 34760083 | 20,137,637 | 2021 |
What is the weight of the patient? | Therapeutic challenge: Unusual coexistence of idiopathic central diabetes insipidus and diabetes mellitus in a male with vitiligo.
Idiopathic central diabetes insipidus (DI) is a rare endocrine disorder that results from total or partial deficiency of vasopressin secretion. It is idiopathic when the cause is unknown, b... | 81 kg. | Weight | CC BY | 34760083 | 20,372,357 | 2021 |
What was the outcome of reaction 'Diabetes mellitus'? | Therapeutic challenge: Unusual coexistence of idiopathic central diabetes insipidus and diabetes mellitus in a male with vitiligo.
Idiopathic central diabetes insipidus (DI) is a rare endocrine disorder that results from total or partial deficiency of vasopressin secretion. It is idiopathic when the cause is unknown, b... | Recovering | ReactionOutcome | CC BY | 34760083 | 20,385,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug dependence'. | Zolpidem withdrawal seizure in an Iranian young woman: A case presentation.
Zolpidem is a non-benzodiazepine drug, approved by FDA for sleep induction. Zolpidem is thought to be a safer drug than benzodiazepines (BZD) because of no evidence of abuse or dependence potential, but several case reports of zolpidem abuse an... | ACYCLOVIR, SERTRALINE HYDROCHLORIDE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34760086 | 19,928,088 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug withdrawal convulsions'. | Zolpidem withdrawal seizure in an Iranian young woman: A case presentation.
Zolpidem is a non-benzodiazepine drug, approved by FDA for sleep induction. Zolpidem is thought to be a safer drug than benzodiazepines (BZD) because of no evidence of abuse or dependence potential, but several case reports of zolpidem abuse an... | ACYCLOVIR, SERTRALINE HYDROCHLORIDE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34760086 | 19,928,088 | 2021 |
What was the outcome of reaction 'Drug withdrawal convulsions'? | Zolpidem withdrawal seizure in an Iranian young woman: A case presentation.
Zolpidem is a non-benzodiazepine drug, approved by FDA for sleep induction. Zolpidem is thought to be a safer drug than benzodiazepines (BZD) because of no evidence of abuse or dependence potential, but several case reports of zolpidem abuse an... | Recovered | ReactionOutcome | CC BY | 34760086 | 19,928,088 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia cytomegaloviral'. | Cytomegalovirus pneumonia in an immunosuppressed sarcoidosis patient; a rare case of cytomegalovirus infection in a sarcoidosis patient.
Sarcoidosis is a multisystemic granulomatosis disease that is mostly treated with immunosuppressive regimens. Studies demonstrated that these patients are prone to develop various inf... | CIPROFLOXACIN, MEROPENEM, METHOTREXATE, PREDNISOLONE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34760093 | 19,941,192 | 2021 |
What was the dosage of drug 'METHOTREXATE'? | Cytomegalovirus pneumonia in an immunosuppressed sarcoidosis patient; a rare case of cytomegalovirus infection in a sarcoidosis patient.
Sarcoidosis is a multisystemic granulomatosis disease that is mostly treated with immunosuppressive regimens. Studies demonstrated that these patients are prone to develop various inf... | 10-15MG WEEKLY | DrugDosageText | CC BY | 34760093 | 19,941,192 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | Cytomegalovirus pneumonia in an immunosuppressed sarcoidosis patient; a rare case of cytomegalovirus infection in a sarcoidosis patient.
Sarcoidosis is a multisystemic granulomatosis disease that is mostly treated with immunosuppressive regimens. Studies demonstrated that these patients are prone to develop various inf... | 15-20MG DAILY | DrugDosageText | CC BY | 34760093 | 19,941,192 | 2021 |
What was the outcome of reaction 'Pneumonia cytomegaloviral'? | Cytomegalovirus pneumonia in an immunosuppressed sarcoidosis patient; a rare case of cytomegalovirus infection in a sarcoidosis patient.
Sarcoidosis is a multisystemic granulomatosis disease that is mostly treated with immunosuppressive regimens. Studies demonstrated that these patients are prone to develop various inf... | Recovering | ReactionOutcome | CC BY | 34760093 | 19,941,192 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | FLUOROURACIL, GEMCITABINE, IRINOTECAN, LEUCOVORIN CALCIUM, PACLITAXEL | DrugsGivenReaction | CC BY | 34760094 | 20,556,675 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | CISPLATIN, FLUOROURACIL, GRANISETRON, IRINOTECAN, LEUCOVORIN, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34760094 | 20,525,590 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | FLUOROURACIL, GEMCITABINE, IRINOTECAN, LEUCOVORIN CALCIUM, PACLITAXEL | DrugsGivenReaction | CC BY | 34760094 | 20,556,675 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | CISPLATIN, FLUOROURACIL, GRANISETRON, IRINOTECAN, LEUCOVORIN, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34760094 | 20,525,590 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | CISPLATIN, FLUOROURACIL, GRANISETRON, IRINOTECAN, LEUCOVORIN, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34760094 | 20,525,590 | 2021 |
What was the administration route of drug 'CISPLATIN'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34760094 | 20,525,590 | 2021 |
What was the administration route of drug 'GEMCITABINE'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34760094 | 20,556,675 | 2021 |
What was the administration route of drug 'GRANISETRON'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34760094 | 20,525,590 | 2021 |
What was the administration route of drug 'IRINOTECAN'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34760094 | 20,525,590 | 2021 |
What was the administration route of drug 'LEUCOVORIN CALCIUM'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34760094 | 20,556,675 | 2021 |
What was the administration route of drug 'LEUCOVORIN'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34760094 | 20,525,590 | 2021 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34760094 | 20,525,590 | 2021 |
What was the dosage of drug 'CISPLATIN'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | 60 MILLIGRAM/SQ. METER, CYCLE, INFUSED FOR 2 HOURS ON DAY 1 | DrugDosageText | CC BY | 34760094 | 20,525,590 | 2021 |
What was the dosage of drug 'GEMCITABINE'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | 1 GRAM PER SQUARE METRE ON DAYS 1,8,15 | DrugDosageText | CC BY | 34760094 | 20,556,675 | 2021 |
What was the dosage of drug 'GRANISETRON'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | 80 MILLIGRAM | DrugDosageText | CC BY | 34760094 | 20,525,590 | 2021 |
What was the dosage of drug 'LEUCOVORIN CALCIUM'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | 400 MILLIGRAM/SQ. METER OVER 2 H ON D1; 8 COURSES | DrugDosageText | CC BY | 34760094 | 20,556,675 | 2021 |
What was the dosage of drug 'LEUCOVORIN'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | 400 MILLIGRAM/SQ. METER, CYCLE, OVER 2 HOUR ON DAY 1; FOLFIRI REGIMEN | DrugDosageText | CC BY | 34760094 | 20,525,590 | 2021 |
What was the dosage of drug 'PACLITAXEL'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | 125 MILLIGRAM/SQ. METER | DrugDosageText | CC BY | 34760094 | 20,556,675 | 2021 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | 1 LITER, ON DAY 1 THROUGH DAY 5 | DrugDosageText | CC BY | 34760094 | 20,525,590 | 2021 |
What was the outcome of reaction 'Disease progression'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | Fatal | ReactionOutcome | CC BY | 34760094 | 20,556,675 | 2021 |
What was the outcome of reaction 'Nausea'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | Recovered | ReactionOutcome | CC BY | 34760094 | 20,525,590 | 2021 |
What was the outcome of reaction 'Vomiting'? | Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer.
Primary squamous cell carcinoma (SCC) of the pancreas is a rare tumor and associated with poor prognosis. The diagnosis and optimal management of patients is still a matter of debate and not well-defined. Limited chemotherapy protocols, r... | Recovered | ReactionOutcome | CC BY | 34760094 | 20,525,590 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Electrophysiologic findings in patients with COVID-19 and quadriparesia in the northwest of Iran, A case series study and literature review.
As a global health pandemic, the novel severe acute respiratory syndrome-coronavirus 2 (SARS- CoV2) outbreak began in December 2019 which rapidly spread to more than 200 countries... | AZITHROMYCIN, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34760104 | 20,456,162 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Facial paralysis'. | A Case Report of Acute Transient Encephalopathy Following a Trans-esophageal Echocardiography.
Methemoglobinemia is caused due to an increase in methemoglobin in the blood, impairing oxygen transfer to tissues. Acquired methemoglobinemia is caused by various drugs like local anesthetics, antibiotics, nitrates, nitrites... | BENZOCAINE, LIDOCAINE | DrugsGivenReaction | CC BY | 34760423 | 20,137,570 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Methaemoglobinaemia'. | A Case Report of Acute Transient Encephalopathy Following a Trans-esophageal Echocardiography.
Methemoglobinemia is caused due to an increase in methemoglobin in the blood, impairing oxygen transfer to tissues. Acquired methemoglobinemia is caused by various drugs like local anesthetics, antibiotics, nitrates, nitrites... | BENZOCAINE, LIDOCAINE | DrugsGivenReaction | CC BY | 34760423 | 20,137,570 | 2021-10 |
What was the administration route of drug 'BENZOCAINE'? | A Case Report of Acute Transient Encephalopathy Following a Trans-esophageal Echocardiography.
Methemoglobinemia is caused due to an increase in methemoglobin in the blood, impairing oxygen transfer to tissues. Acquired methemoglobinemia is caused by various drugs like local anesthetics, antibiotics, nitrates, nitrites... | Topical | DrugAdministrationRoute | CC BY | 34760423 | 20,137,570 | 2021-10 |
What was the administration route of drug 'LIDOCAINE'? | A Case Report of Acute Transient Encephalopathy Following a Trans-esophageal Echocardiography.
Methemoglobinemia is caused due to an increase in methemoglobin in the blood, impairing oxygen transfer to tissues. Acquired methemoglobinemia is caused by various drugs like local anesthetics, antibiotics, nitrates, nitrites... | Topical | DrugAdministrationRoute | CC BY | 34760423 | 20,137,570 | 2021-10 |
What was the outcome of reaction 'Facial paralysis'? | A Case Report of Acute Transient Encephalopathy Following a Trans-esophageal Echocardiography.
Methemoglobinemia is caused due to an increase in methemoglobin in the blood, impairing oxygen transfer to tissues. Acquired methemoglobinemia is caused by various drugs like local anesthetics, antibiotics, nitrates, nitrites... | Recovered | ReactionOutcome | CC BY | 34760423 | 20,137,570 | 2021-10 |
What was the outcome of reaction 'Methaemoglobinaemia'? | A Case Report of Acute Transient Encephalopathy Following a Trans-esophageal Echocardiography.
Methemoglobinemia is caused due to an increase in methemoglobin in the blood, impairing oxygen transfer to tissues. Acquired methemoglobinemia is caused by various drugs like local anesthetics, antibiotics, nitrates, nitrites... | Recovered | ReactionOutcome | CC BY | 34760423 | 20,137,570 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | A case series of morbid COPD exacerbations during immune checkpoint inhibitor therapy in cancer patients.
Immune checkpoint inhibitor therapy is rapidly becoming front line adjuvant or primary therapy in a number of solid cancer types. Since many of these cancers are a result of tobacco smoking, a large number of these... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC-ND | 34760616 | 20,106,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | A case series of morbid COPD exacerbations during immune checkpoint inhibitor therapy in cancer patients.
Immune checkpoint inhibitor therapy is rapidly becoming front line adjuvant or primary therapy in a number of solid cancer types. Since many of these cancers are a result of tobacco smoking, a large number of these... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC-ND | 34760616 | 20,106,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A case series of morbid COPD exacerbations during immune checkpoint inhibitor therapy in cancer patients.
Immune checkpoint inhibitor therapy is rapidly becoming front line adjuvant or primary therapy in a number of solid cancer types. Since many of these cancers are a result of tobacco smoking, a large number of these... | NIVOLUMAB | DrugsGivenReaction | CC BY-NC-ND | 34760616 | 20,103,760 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Type 1 diabetes mellitus'. | A case series of morbid COPD exacerbations during immune checkpoint inhibitor therapy in cancer patients.
Immune checkpoint inhibitor therapy is rapidly becoming front line adjuvant or primary therapy in a number of solid cancer types. Since many of these cancers are a result of tobacco smoking, a large number of these... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34760616 | 20,692,691 | 2021 |
What was the dosage of drug 'IPILIMUMAB'? | A case series of morbid COPD exacerbations during immune checkpoint inhibitor therapy in cancer patients.
Immune checkpoint inhibitor therapy is rapidly becoming front line adjuvant or primary therapy in a number of solid cancer types. Since many of these cancers are a result of tobacco smoking, a large number of these... | 3 DOSES | DrugDosageText | CC BY-NC-ND | 34760616 | 20,106,589 | 2021 |
What was the outcome of reaction 'Chronic obstructive pulmonary disease'? | A case series of morbid COPD exacerbations during immune checkpoint inhibitor therapy in cancer patients.
Immune checkpoint inhibitor therapy is rapidly becoming front line adjuvant or primary therapy in a number of solid cancer types. Since many of these cancers are a result of tobacco smoking, a large number of these... | Fatal | ReactionOutcome | CC BY-NC-ND | 34760616 | 20,692,691 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Iatrogenic Kaposi's sarcoma unmasked by Vedolizumab in a patient with ulcerative colitis and well-controlled human immunodeficiency virus: A case report.
Kaposi sarcoma (KS) was first described by Moritz Kaposi as a vascular tumor that mainly involves the skin but can affect any organ system. It is typically an acquire... | MESALAMINE, VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC-SA | 34760665 | 20,108,880 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Human herpesvirus 8 infection'. | Iatrogenic Kaposi's sarcoma unmasked by Vedolizumab in a patient with ulcerative colitis and well-controlled human immunodeficiency virus: A case report.
Kaposi sarcoma (KS) was first described by Moritz Kaposi as a vascular tumor that mainly involves the skin but can affect any organ system. It is typically an acquire... | MESALAMINE, VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC-SA | 34760665 | 20,108,880 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Kaposi^s sarcoma'. | Iatrogenic Kaposi's sarcoma unmasked by Vedolizumab in a patient with ulcerative colitis and well-controlled human immunodeficiency virus: A case report.
Kaposi sarcoma (KS) was first described by Moritz Kaposi as a vascular tumor that mainly involves the skin but can affect any organ system. It is typically an acquire... | MESALAMINE, VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC-SA | 34760665 | 20,108,880 | 2021 |
What was the administration route of drug 'OSIMERTINIB'? | Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases.
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) are the standard of care for non-s... | Oral | DrugAdministrationRoute | CC BY | 34760695 | 20,614,057 | 2021 |
What was the dosage of drug 'BEVACIZUMAB'? | Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases.
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) are the standard of care for non-s... | 400 MG/MONTH | DrugDosageText | CC BY | 34760695 | 20,614,057 | 2021 |
What was the dosage of drug 'OSIMERTINIB'? | Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases.
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) are the standard of care for non-s... | 80 mg (milligrams). | DrugDosage | CC BY | 34760695 | 20,614,057 | 2021 |
What was the outcome of reaction 'Cardiac failure'? | Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases.
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) are the standard of care for non-s... | Recovering | ReactionOutcome | CC BY | 34760695 | 20,614,057 | 2021 |
What was the outcome of reaction 'Nausea'? | Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases.
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) are the standard of care for non-s... | Recovered | ReactionOutcome | CC BY | 34760695 | 20,614,057 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Subdural haematoma'. | Cerebral Venous Thrombosis Caused by Spontaneous Intracranial Hypotension: A Case Report.
This case report presents a rare case of cerebral venous thrombosis (CVT) caused by spontaneous intracranial hypotension (SIH). The cause and prognosis of CVT can vary; CVT caused by SIH is uncommon and difficult to diagnose and t... | APIXABAN | DrugsGivenReaction | CC BY-NC | 34760830 | 20,045,697 | 2021-10 |
What was the administration route of drug 'APIXABAN'? | Cerebral Venous Thrombosis Caused by Spontaneous Intracranial Hypotension: A Case Report.
This case report presents a rare case of cerebral venous thrombosis (CVT) caused by spontaneous intracranial hypotension (SIH). The cause and prognosis of CVT can vary; CVT caused by SIH is uncommon and difficult to diagnose and t... | Oral | DrugAdministrationRoute | CC BY-NC | 34760830 | 20,045,697 | 2021-10 |
What was the outcome of reaction 'Subdural haematoma'? | Cerebral Venous Thrombosis Caused by Spontaneous Intracranial Hypotension: A Case Report.
This case report presents a rare case of cerebral venous thrombosis (CVT) caused by spontaneous intracranial hypotension (SIH). The cause and prognosis of CVT can vary; CVT caused by SIH is uncommon and difficult to diagnose and t... | Recovered | ReactionOutcome | CC BY-NC | 34760830 | 20,045,697 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis'. | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | ACYCLOVIR, AMPHOTERICIN B, INFLIXIMAB, INTERFERON GAMMA, ITRACONAZOLE, MEROPENEM, MICAFUNGIN, POSACONAZOLE, PREDNISONE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VANCOMYCIN | DrugsGivenReaction | CC BY | 34760850 | 20,683,214 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | ACYCLOVIR | DrugsGivenReaction | CC BY | 34760850 | 20,893,370 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella infection'. | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | INFLIXIMAB, POSACONAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 34760850 | 20,630,850 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | AMOXICILLIN, CLARITHROMYCIN, INFLIXIMAB, LANSOPRAZOLE, POSACONAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 34760850 | 20,093,225 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oral herpes'. | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | INFLIXIMAB, POSACONAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 34760850 | 20,105,228 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia klebsiella'. | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | AMOXICILLIN, CLARITHROMYCIN, INFLIXIMAB, INTERFERON GAMMA-1B, LANSOPRAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 34760850 | 20,634,531 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Systemic candida'. | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | INFLIXIMAB, POSACONAZOLE, PREDNISONE | DrugsGivenReaction | CC BY | 34760850 | 20,105,228 | 2021 |
What was the administration route of drug 'INFLIXIMAB'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | Other | DrugAdministrationRoute | CC BY | 34760850 | 20,630,850 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | Oral | DrugAdministrationRoute | CC BY | 34760850 | 20,683,214 | 2021 |
What was the dosage of drug 'AMOXICILLIN'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | UNKNOWN | DrugDosageText | CC BY | 34760850 | 20,093,225 | 2021 |
What was the dosage of drug 'CLARITHROMYCIN'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | UNKNOWN | DrugDosageText | CC BY | 34760850 | 20,093,225 | 2021 |
What was the dosage of drug 'LANSOPRAZOLE'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | UNKNOWN | DrugDosageText | CC BY | 34760850 | 20,093,225 | 2021 |
What was the dosage of drug 'POSACONAZOLE'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | UNKNOWN | DrugDosageText | CC BY | 34760850 | 20,093,225 | 2021 |
What was the outcome of reaction 'Candida infection'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | Recovered | ReactionOutcome | CC BY | 34760850 | 20,630,850 | 2021 |
What was the outcome of reaction 'Lymphadenitis fungal'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | Recovered | ReactionOutcome | CC BY | 34760850 | 20,630,850 | 2021 |
What was the outcome of reaction 'Lymphadenitis'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | Recovered | ReactionOutcome | CC BY | 34760850 | 20,683,214 | 2021 |
What was the outcome of reaction 'Oral herpes'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | Recovered | ReactionOutcome | CC BY | 34760850 | 20,105,228 | 2021 |
What was the outcome of reaction 'Systemic candida'? | Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review.
Chronic granulomatous disease (CGD) is an inborn error of immunity caused by inactivating genetic mutations in any one of the components of the p... | Recovered | ReactionOutcome | CC BY | 34760850 | 20,105,228 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | NKX2.1 (TTF1) germline mutation associated with pulmonary fibrosis and lung cancer.
Germline surfactant-associated genes mutations are associated with ILD and increased risk of lung cancer https://bit.ly/3CkkXgD.
pmc To the Editor:
The high prevalence of lung cancer in patients with idiopathic pulmonary fibrosis (3–30... | CARBOPLATIN, NINTEDANIB, PEMETREXED, PIRFENIDONE, PREDNISONE | DrugsGivenReaction | CC BY-NC | 34760996 | 20,416,367 | 2021-10 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.